منابع مشابه
Post-marketing surveillance of buprenorphine.
PURPOSE This study was undertaken to evaluate the adverse consequences of recently introduced higher strength (0.4 and 2.0 mg per tablet) buprenorphine in Indian market. Buprenorphine, a partial opiate agonist and antagonist, is an emerging alternative to methadone as an agent for long-term treatment of opiate dependence. METHODS The current investigation was conducted through a multi-centric...
متن کاملSodium Oxybate for Narcolepsy
1a. Is sodium oxybate safe and clinically effective in the reduction in number and intensity of cataplexy attack, excessive day-time sleepiness (diurnal naps), nocturnal awakenings, terrifying dream experiences, insomnia, hypnagogic hallucinations, sleep paralysis, and improvement in quality of life in adult patients with narcolepsy and cataplexy compared to no intervention, combined treatment ...
متن کاملPost Marketing Surveillance on Propranolol and Atenolol Tablets Manufactured in Iran
Propranolol, a prototypical b-adrenergic receptor antagonist and atenolol, a cardio-selective b-antagonist are widely used in therapeutic regimens for treatment of hypertensive patients. In Iran, several pharmaceutical manufacturers formulate these two b-blockers. As the formulation of a dosage form is essential for the patient's safety and drug efficacy, in this study we aimed to evalu...
متن کاملDifferential Effects of Sodium Oxybate and Baclofen
1071 GABAB Agonist, Sleep, and the EEG—Vienne et al INTRODUCTION Sodium oxybate (SO, sodium salt of γ-hydroxybutyric acid [GHB]) is an endogenously produced fatty acid, recently approved for the treatment of narcolepsy with cataplexy.1 GHB has been shown to increase slow wave sleep (SWS) and EEG delta power (0.75-4.5 Hz), in a dose-dependent manner in healthy subjects2-4 and in patients with na...
متن کاملPost marketing surveillance of sublingual buprenorphine naloxone combination tablets.
BACKGROUND & OBJECTIVES A combination of buprenorphine-naloxone (Addnok-N) tablets has been recently introduced in India as treatment for Opioid dependence. This study was undertaken to evaluate the possible adverse consequences following use of the buprenorphine-naloxone tablets through post marketing surveillance. METHODS National Drug Dependence Treatment Centre (NDDTC), AIIMS, India, moni...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Sleep Medicine
سال: 2011
ISSN: 1550-9389,1550-9397
DOI: 10.5664/jcsm.1216